학술논문

Investigation of modifier genes within copy number variations in Rett syndrome
Document Type
article
Source
Journal of Human Genetics. 56(7)
Subject
Biological Sciences
Biomedical and Clinical Sciences
Genetics
Pediatric
Neurosciences
Brain Disorders
Rare Diseases
Rett Syndrome
Neurodegenerative
Aetiology
2.1 Biological and endogenous factors
Blood Proteins
Chromatin Immunoprecipitation
Chromosomes
Human
Pair 1
Complement C3b Inactivator Proteins
Cytoskeletal Proteins
DNA Copy Number Variations
Female
Humans
Methyl-CpG-Binding Protein 2
Phenotype
copy number variants
modifier genes
Rett syndrome
Clinical Sciences
Genetics & Heredity
Clinical sciences
Language
Abstract
MECP2 mutations are responsible for two different phenotypes in females, classical Rett syndrome and the milder Zappella variant (Z-RTT). We investigated whether copy number variants (CNVs) may modulate the phenotype by comparison of array-CGH data from two discordant pairs of sisters and four additional discordant pairs of unrelated girls matched by mutation type. We also searched for potential MeCP2 targets within CNVs by chromatin immunopreceipitation microarray (ChIP-chip) analysis. We did not identify one major common gene/region, suggesting that modifiers may be complex and variable between cases. However, we detected CNVs correlating with disease severity that contain candidate modifiers. CROCC (1p36.13) is a potential MeCP2 target, in which a duplication in a Z-RTT and a deletion in a classic patient were observed. CROCC encodes a structural component of ciliary motility that is required for correct brain development. CFHR1 and CFHR3, on 1q31.3, may be involved in the regulation of complement during synapse elimination, and were found to be deleted in a Z-RTT but duplicated in two classic patients. The duplication of 10q11.22, present in two Z-RTT patients, includes GPRIN2, a regulator of neurite outgrowth and PPYR1, involved in energy homeostasis. Functional analyses are necessary to confirm candidates and to define targets for future therapies.